Concepedia

Publication | Open Access

The effect of Benzothiazolone‐2 on the expression of Metallothionein‐3 in modulating Alzheimer's disease

14

Citations

18

References

2017

Year

Abstract

Benzothiazolone-2 compounds significantly enhanced MT-3 protein and mRNA levels. The compounds can be looked upon as one of the probable lead compounds for future drug designing experiments in the treatment of Alzheimer's disease.

References

YearCitations

Page 1